{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:49:27Z","timestamp":1786373367017,"version":"build-2736575974"},"reference-count":4,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["75N94019C00006"],"award-info":[{"award-number":["75N94019C00006"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["CJASN"],"published-print":{"date-parts":[[2022,3]]},"abstract":"<jats:p>Measures implemented to prevent transmission of severe acute respiratory syndrome coronavirus 2 in outpatient dialysis facilities may also help to prevent catheter-associated bloodstream infections in patients receiving hemodialysis. We used United States Renal Data System data to examine rates of antibiotic administration within dialysis facilities and rates of hospital admission for catheter-associated bloodstream infection from March 2018 through November 2020, and rates of hospitalization for sepsis, to address overall changes in hospitalization during the coronavirus disease 2019 (COVID-19) pandemic. Using logistic regression, we estimated year-over-year adjusted odds ratios of these events in 3-month intervals. During the first 6 months of the pandemic, rates of antibiotic administration were between 20% and 21% lower, and rates of hospitalization for catheter-associated bloodstream infection were between 17% and 24% lower than during corresponding periods in 2019, without significant changes in rates of hospitalization for sepsis. However, rates of catheter-associated events also decreased between 2018 and 2019, driven by reductions in facilities operated by a large dialysis provider. These data suggest that significant reductions in catheter-associated infections occurred during the pandemic, superimposed on nonpandemic-related reductions in some facilities before the pandemic. Even after the pandemic, it may be prudent to continue some COVID-19 mitigation measures to prevent catheter-associated bloodstream infections.<\/jats:p>","DOI":"10.2215\/cjn.11360821","type":"journal-article","created":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T11:05:17Z","timestamp":1643799917000},"page":"429-433","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":16,"title":["Catheter-Associated Bloodstream Infections among Patients on Hemodialysis"],"prefix":"10.2215","volume":"17","author":[{"given":"Kirsten L.","family":"Johansen","sequence":"first","affiliation":[{"name":"Chronic Disease Research Group, Hennepin Healthcare Research Institute, Minneapolis, Minnesota"},{"name":"Division of Nephrology, Hennepin Healthcare, Minneapolis, Minnesota"},{"name":"Department of Medicine, University of Minnesota, Minneapolis, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David T.","family":"Gilbertson","sequence":"additional","affiliation":[{"name":"Chronic Disease Research Group, Hennepin Healthcare Research Institute, Minneapolis, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1380-8597","authenticated-orcid":false,"given":"James B.","family":"Wetmore","sequence":"additional","affiliation":[{"name":"Chronic Disease Research Group, Hennepin Healthcare Research Institute, Minneapolis, Minnesota"},{"name":"Division of Nephrology, Hennepin Healthcare, Minneapolis, Minnesota"},{"name":"Department of Medicine, University of Minnesota, Minneapolis, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Peng","sequence":"additional","affiliation":[{"name":"Chronic Disease Research Group, Hennepin Healthcare Research Institute, Minneapolis, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiannong","family":"Liu","sequence":"additional","affiliation":[{"name":"Chronic Disease Research Group, Hennepin Healthcare Research Institute, Minneapolis, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8016-2015","authenticated-orcid":false,"given":"Eric D.","family":"Weinhandl","sequence":"additional","affiliation":[{"name":"Chronic Disease Research Group, Hennepin Healthcare Research Institute, Minneapolis, Minnesota"},{"name":"Department of Pharmaceutical Care and Health Systems, University of Minnesota, Minneapolis, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2022,3]]},"reference":[{"key":"B3-20241015","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.2215\/CJN.07220521","article-title":"Evidence-based practices to reduce COVID-19 transmission in dialysis facilities","volume":"16","author":"Kliger","year":"2021","journal-title":"Clin J Am Soc Nephrol"},{"key":"B5-20241015","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1053\/j.ajkd.2013.03.011","article-title":"Bloodstream infection rates in outpatient hemodialysis facilities participating in a collaborative prevention effort: A quality improvement report","volume":"62","author":"Patel","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"B6-20241015","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1017\/ice.2016.22","article-title":"Sustained infection reduction in outpatient hemodialysis centers participating in a collaborative bloodstream infection prevention effort","volume":"37","author":"Yi","year":"2016","journal-title":"Infect Control Hosp Epidemiol"},{"key":"B7-20241015","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1053\/j.ajkd.2016.09.014","article-title":"Dialysis catheter-related bloodstream infections: A cluster-randomized trial of the ClearGuard HD antimicrobial barrier cap","volume":"69","author":"Hymes","year":"2017","journal-title":"Am J Kidney Dis"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.11360821","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:45:19Z","timestamp":1786369519000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.2215\/CJN.11360821"}},"subtitle":["Progress before and during the COVID-19 Pandemic"],"short-title":[],"issued":{"date-parts":[[2022,3]]},"references-count":4,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.11360821","relation":{},"ISSN":["1555-9041","1555-905X"],"issn-type":[{"value":"1555-9041","type":"print"},{"value":"1555-905X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3]]}}}